Role of corticosteroids in infectious disease

La Presse médicale
Elisabeth Aslangul, Claire Le Jeunne

Abstract

Corticosteroids, when used in prolonged treatments, increase the chances of bacterial and fungal infections. The advantage of corticotherapy combined with specific anti-infective treatment has been proven for certain bacterial and fungal infections. There is no evidence favouring the prescription of anti-inflammatory corticosteroids for infections in the ENT area. Corticosteroids, even in short-term treatments, must always be prescribed in combination with antibiotics in the course of infections. Corticosteroids make it possible to limit the deleterious effects caused by the activation of the immune system at the time of certain infections, and lesions linked to acute inflammation. The duration of the prescription of corticosteroids must be reduced to a minimum during sepsis.

References

Mar 1, 1991·The Pediatric Infectious Disease Journal·N I GirgisI A Mikhail
Sep 10, 1987·The New England Journal of Medicine·UNKNOWN Veterans Administration Systemic Sepsis Cooperative Study Group
Oct 13, 1988·The New England Journal of Medicine·M H LebelG H McCracken
Dec 17, 1987·The New England Journal of Medicine·G R BernardC A Metz
Jul 1, 1969·The American Journal of Medicine·A L BlumG F Grady
Apr 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S WalmsleyI Salit
Jun 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S KumarveluG K Ahuja
Feb 6, 1998·The American Journal of Tropical Medicine and Hygiene·N I GirgisA J Mateczun
Apr 29, 1998·Critical Care Medicine·P E BollaertA Larcan
Jul 21, 1998·JAMA : the Journal of the American Medical Association·G U MeduriE A Tolley
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Nov 12, 2002·American Journal of Respiratory and Critical Care Medicine·Didier KehHerwig Gerlach
Nov 15, 2002·The New England Journal of Medicine·Jan de GansUNKNOWN European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators
Jul 17, 2004·QJM : Monthly Journal of the Association of Physicians·J I G StrangD J Girling
Oct 22, 2004·The New England Journal of Medicine·Guy E ThwaitesJeremy J Farrar
Jan 11, 2005·Lancet·Djillali AnnaneJean-Marc Cavaillon
Apr 21, 2006·The New England Journal of Medicine·Kenneth P SteinbergUNKNOWN National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network
Jan 24, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martijn D de KruifTom van der Poll
Aug 25, 2007·BMJ : British Medical Journal·Susannah K Leaver, Timothy W Evans
Dec 14, 2007·The New England Journal of Medicine·Thi Hoang Mai NguyenJeremy J Farrar
Jan 11, 2008·The New England Journal of Medicine·Charles L SprungUNKNOWN CORTICUS Study Group
Apr 7, 2009·Scandinavian Journal of Infectious Diseases·Ira Shah
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Djillali AnnaneG Umberto Meduri

❮ Previous
Next ❯

Citations

Aug 28, 2015·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Natalya AzadehJanis E Blair
Jul 25, 2021·Acta otorrinolaringológica española·Andrés LimardoAdrían Ortega

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.